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http://www.biomedcentral.com/1471-2164/15/550RESEARCH ARTICLE Open AccessDesign and development of exome capture
sequencing for the domestic pig (Sus scrofa)
Christelle Robert1, Pablo Fuentes-Utrilla1,2, Karen Troup1,2, Julia Loecherbach1,2, Frances Turner1,2, Richard Talbot1,2,
Alan L Archibald1, Alan Mileham3, Nader Deeb4, David A Hume1 and Mick Watson1,2*Abstract
Background: The domestic pig (Sus scrofa) is both an important livestock species and a model for biomedical
research. Exome sequencing has accelerated identification of protein-coding variants underlying phenotypic traits in
human and mouse. We aimed to develop and validate a similar resource for the pig.
Results: We developed probe sets to capture pig exonic sequences based upon the current Ensembl pig gene
annotation supplemented with mapped expressed sequence tags (ESTs) and demonstrated proof-of-principle
capture and sequencing of the pig exome in 96 pigs, encompassing 24 capture experiments. For most of the
samples at least 10x sequence coverage was achieved for more than 90% of the target bases. Bioinformatic analysis
of the data revealed over 236,000 high confidence predicted SNPs and over 28,000 predicted indels.
Conclusions: We have achieved coverage statistics similar to those seen with commercially available human and
mouse exome kits. Exome capture in pigs provides a tool to identify coding region variation associated with
production traits, including loss of function mutations which may explain embryonic and neonatal losses, and to
improve genomic assemblies in the vicinity of protein coding genes in the pig.Background
Reductions in the cost of DNA sequencing [1], have
brought the large scale sequencing of individual human
genomes within reach financially and there are claims
that the $1000 human genome is now achievable. Low
cost sequencing has facilitated the sequencing of mul-
tiple human genomes and analysis of these genomes has
revealed that most individuals harbour hundreds of dele-
terious mutations [2]. In humans, approximately 85% of
known disease-causing mutations can be found within
the coding region or splice sites of protein-coding genes
[3]. Whilst this number may be biased by studies fo-
cused only on protein-coding genes, exome sequencing
has nevertheless become a standard tool in the search
for the cause of monogenic disorders in humans [3-7].
Exome capture was initially carried out using micro-
arrays [8,9] but current methods, such as Agilent’s* Correspondence: mick.watson@roslin.ed.ac.uk
1The Roslin Institute and Royal (Dick) School of Veterinary Studies, University
of Edinburgh, Easter Bush, Edinburgh EH25 9RG, UK
2Edinburgh Genomics, University of Edinburgh, Easter Bush, Edinburgh EH25
9RG, UK
Full list of author information is available at the end of the article
© 2014 Robert et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.SureSelect and Nimblegen’s SeqCap EZ systems rely on
liquid capture [10,11].
Global pig meat production has risen by 60% in the
last decade and now accounts for approximately one
third of all meat produced worldwide. One of the key
aims of farm animal genetics and genomics research is
to discover the genes underlying important traits such as
disease resistance/susceptibility, feed efficiency, product
quality and reproductive performance. Whereas many
quantitative traits are linked to variation in gene expres-
sion, the initial sequencing of the pig genome revealed
that individual pigs also harbour significant numbers of
potentially deleterious protein-coding mutations [12].
As has been noted in the recent identification of the
lethal recessive gene in Holstein cattle that causes bra-
chyspina [13], and a mutation in the CWC15 gene in
Jersey cattle associated with reduced fertility [14], such
mutations can be present at high frequency in livestock
populations and lead to significant fetal loss. At least
some of the large numbers of pre-natal and pre-weaning
embryo losses in pigs (up to 40% [15]) are also likely to
be due to homozygous lethal mutations.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Comparison of exome regions. The size of the core
Ensembl protein-coding exome in a range of species, including
human, important agricultural species (chicken, cattle, pig); important
rodent model species (rat, mouse); and important primate (gorilla,
chimp) species.
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right, the pig is an important model for human disease
[16,17]. Pigs resemble humans in terms of development
and physiology, and pig and human genomes are much
more closely related than the human and mouse [12,18].
Pigs are also more closely related to humans in terms of
their innate immune-responses [19]. The combination of
the rapid identification of natural null mutations by
exome sequence analyses along with the option to estab-
lish brother-sister mating in a multiparous animal will
facilitate the development of models based on homo-
zygous natural null mutations. Such models will be va-
luable for basic and strategic biological and biomedical
research.
Here we describe the design and development of an
exome capture for the domestic pig Sus scrofa, based on
the Ensembl [20] annotation of assembly version 10.2 of
the genome [12]. We have augmented the design for the
capture probe set with additional known expressed se-
quences from UniGene [21]. We provide comprehensive
statistics from a pilot study in which the exomes of 96 pigs
were sequenced using the Roche Nimblegen SeqCAP EZ
system and the Illumina HiSeq 2500 platform. Our
bioinformatic analyses, using variant discovery pipelines
based on GATK [22], revealed several hundred thousand
putative high quality variants within our capture region,
demonstrating the power of exome sequencing. The
results indicate that each individual pig harbours several
thousand non-synonymous amino acid substitutions.
Results
Definition of the capture region
The exons of protein coding genes from release 71 of
the Ensembl genebuild for Sus scrofa sum to a total
length of 44.6 Mb, compared to 73.4 Mb for human and
67.1 Mb for mouse (Figure 1). These figures for the
human and murine genomes exclude alternative hap-
lotypes. Assuming that pig does not have a smaller ex-
ome than mouse or human, there is probably 22.5 to
28.8 Mb missing from the current pig genome assembly
and Ensembl annotation of the current pig genome.
By mapping publicly available expressed sequence tags
(ESTs) to the reference genome, we were able to identify
expressed regions that were not covered by the Ensembl
gene set. The “ensembl + ests” capture region covers
58.1 Mb, suggesting there is still between 9 and 15.3 Mb
missing once additional EST alignments have been
taken into account.
Based upon mapping of the ESTs and cDNAs from
UniGene to the current pig reference genome in Ensembl,
we were able to identify two classes of gene: (i) those
genes present in the pig assembly, but either wholly or
partially absent in the Ensembl gene build; and (ii) those
genes completely absent from the assembly.Figures 2 and 3 show examples where very good align-
ments of ESTs to the genome are achievable but have not
been included in the core Ensembl gene set. The region in
Figure 2 shows an alignment against the latest pig re-
ference of an 11 kb Sus scrofa mRNA from UniGene,
a putative SMG1 phosphatidylinositol 3-kinase-related
kinase homologous to the human SMG1 gene. Align-
ments to several cDNA and EST sequences are annotated
in Ensembl in this region (22,400-100,300 bp) on unplaced
scaffold GL894597.1 but no Ensembl gene model has been
built or core gene defined. A gene model for the ARL6IP1
gene is annotated on this scaffold in the adjacent 10 kb
interval (GL894597.1:100000–111000). The human homo-
logues of SMG1 and ARL6IP1 are co-located in a 140 kb
interval on human chromosome 16. NCBI annotation of
the pig genome includes a gene model for SMG1 at this
location. Similarly, Figure 3 shows a region of pig chro-
mosome 2 (2:100,918,831-100,958,358 bp) matching an
8.7 kb mRNA from UniGene, which represents a putative
G protein-coupled receptor 98 (GPCR 98) mRNA. NCBI
annotation of the pig genome includes a gene model for
LOC100519889 G-protein coupled receptor 98-like at this
location. In humans the GPR98 gene with >90 exons and
11 annotated transcripts spans 635 kb on human chromo-
some 5 and is flanked by the LYSMD3 and ARRDC3
genes. In the homologous interval between the LYSDM3
and ARRDC3 loci on pig chromosome 2 a small GPR98
gene model with 3 exons spanning ~13 kb is annotated in
Ensembl. Hence the Ensembl pig GPR98 gene model
probably represents only a fraction of the pig GPR98
exons and gene.
Anther gene only partially represented in the Ensembl
gene build is IGF2 (insulin-like growth factor 2), which
plays a key role in mammalian growth and development
Figure 2 Additional gene: putative SMG1 phosphatidylinositol 3-kinase. Genomic region displayed in Ensembl with good alignment to a
UniGene mRNA sequence representing an 11 kb putative SMG1 phosphatidylinositol 3-kinase-related sequence which is homologous to the human
SMG1 gene. Alignments to several cDNA and EST sequences are annotated in Ensembl in this region (22,400-100,300 bp) on unplaced scaffold
GL894597.1 but no Ensembl gene model has been built or core gene defined. The red regions show the pig exome capture regions described in this
paper, derived from alignments of UniGene sequences against the genome (see “Methods”). NCBI annotation of the pig genome includes a gene
model for SMG1 at this location.
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in detail including the identification of a point mutation
with significant effects on muscling [24], there is only
a fragment of the gene in the published pig genome
sequence (Sscrofa10.2; [12]). In Ensembl version 71, this
gene is represented by transcript ENSSSCT00000022466,
consisting of 195 bp. The corresponding genomic region
is represented by multiple small contigs separated by
gaps. In contrast, sequence accession X56094 is a 1225 bp
mRNA sequence representing the Sus scrofa IGF2.
Figure 4 shows a dot-plot comparing these two sequences,
and demonstrates that ENSSSCT00000022466 represents
only a fragment of the full-length IGF2 mRNA.
In total, we aligned 50,106 publicly available mRNA
and EST sequences from Sus scrofa Unigene to the latest
pig genome build, and added 39,635 additional high
scoring alignments to the proposed capture region be-
fore merging and filtering the dataset (see “Methods”). A
further 95 full length mRNA sequences were not detect-
able at all in the assembly, and these were added to the
target capture as FASTA sequences. These are listed in
Additional file 1: Table S1.Figure 3 Additional gene: putative GPCR98. Genomic region displayed
representing an 8.7 kb putative GPCR98 mRNA. Alignments to cDNA an
(100,918,831-100,958,358 bp) on chromosome 2 but no Ensembl gene mod
exome capture regions described in this paper, derived from alignments of UProbe design and size of the final target region
Target genomic regions were provided in BED format to
Roche Nimblegen for probe design. Any regions less than
100 bp in size were padded equally at both ends to be-
come 100 bp in length. Any genomic regions found to
overlap were subsequently merged to form one con-
tinuous region. Probes were designed to the resulting cap-
ture regions with an additional 100 bp offset. Only those
probes that had high-scoring matches to less than 6 ge-
nomic regions were used in the capture (see Methods).
The probe design resulted in a 60.6 Mb target, with probes
covering 98.4% of the bases in those regions. The design
is available through Roche Nimblegen, design name
130104_Sscr_10_2_MW_EZ_HX1.
Sequence and coverage statistics
We captured and sequenced exomes from a total of 96
pigs, in 16 pools of 6 individual pig DNA samples from
unrelated commercial pigs, using the Illumina HiSeq 2500
platform. The animals whose exomes were sequenced
comprised 96 boars from a commercial synthetic sire line,
born between 2005 and 2012. In order to ensure that thein Ensembl with good alignment to a UniGene mRNA sequence
d EST sequences are annotated in Ensembl in this region
el has been built or core gene defined. The red regions show the pig
niGene sequences against the genome (see “Methods”).
IGF2 mRNA X56094
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Figure 4 Dot plot comparison of Ensembl and EMBL/GenBank
IGF2 mRNA sequences. A dot plot comparison of Ensembl
transcript ENSSSCT00000022466 and sequence accession X56094,
both of which represent IGF2. Clearly, ENSSSCT00000022466
represents only a fragment of the full length mRNA.
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lated animals from within the line using pedigree informa-
tion and previously available information on genotypes.
This sample exceeds the FAO Advisory Group on Animal
Genetic Diversity guidelines which recommend sampling
25 unrelated individuals per breed [25].
Summary statistics for data volumes, mapping and
coverage of the target are given in Table 1, and full re-
sults are given in Additional file 2: Table S2. Between
4.43 and 11.21 Gigabases of sequence data were pro-
duced for each of the 96 samples. Of the 96 samples, 72
achieved at least 90% of the target bases covered to at
least a depth of 10X. The percentage of reads mapping
to the genome was reasonably high (mean 89.62%), and
of those that mapped, a mean of 67.75% overlapped with
the target region. One goal for the future development
of the design will be to improve both of those statistics.
All samples achieved a PCR duplicate rate of less than
10%, with a mean of 3.78%. These values compare fa-
vourably with a previously published evaluation of hu-
man exome capture kits [26].
Figure 5 shows a heatmap of the percentage of bases
covered at a range of depths, from 1X to 50X. Clearly
there is variation in efficiency of capture; C10 for example
shows a decrease in coverage starting at 4X, whereas the
same dip for capture C9 occurs at 15X.Table 1 Summary statistics for sequence volume, mapping an
Stat Read pairs Gbp % mapped % total on target % m
Min 22141118 4.43 83.41 51.27
Max 56000083 11.20 93.96 68.64
Mean 38415939 7.68 89.62 60.74
Summary statistics from the exome sequencing of 96 pigs, showing minimum, max
statistics. The columns in order represent: the statistic calculated; number of read p
reads overlapping with the target region; percentage of the mapped reads overlap
target covered at 1X; percent of bases in target covered at 10X; percent of bases inVariant discovery
Using published pipelines for variant discovery with
GATK [22,27] (see Methods) we predicted 237,334 high
confidence single nucleotide polymorphisms (SNPs) pre-
sent in at least one of the 96 pigs, present at 236,530
unique loci. 199,170 (83.9%) of the predictions have
existing records in dbSNP. 236,608 (99.7%) of the SNPs
are within our target region, and 173,849 (73.2%) overlap
at least one exon in the current Ensembl genebuild. Of
these SNPs, 93.8% were detected in more than one
animal. 167,201 (70.4%) overlap with at least one exon of
a protein-coding gene (including both UTR and CDS
exons). Of the 167,201 SNPs within protein-coding genes,
71,460 (42.7%) overlap non-coding exons and 95,741
(57.3%) overlap a protein-coding region. Finally, of the
95,741 predicted SNPs within protein-coding exons,
60,732 (63.4%) are synonymous mutations, and 34,092
(35.6%) have an effect on the protein sequence. Of the
34,092 non-synonymous SNPs, 26,801 of these are known
in dbSNP (78.6%) and 7291 are novel (21.4%). 399 SNPs
are predicted to introduce a premature stop codon. Of
these, 239 (60%) have an existing record in dbSNP and
160 (40%) are novel. The ratio of synonymous to non-
synonymous mutations is very similar to what has been
reported in humans and by analogy, around 10-20% of the
non-synonymous variants are likely to adversely affect
protein function [28,29]. We have submitted all 237,334
SNPs to dbSNP.
Insertions and deletions (indels) were also predicted
using the GATK pipeline. We predicted 28,976 indels,
28115 (97%) of which overlapped with our target region,
and 18,471 (63.4%) of which overlapped with at least
one exon in the current Ensembl genebuild. 17,503
(60.4%) overlapped an exon from a protein-coding gene.
Of the 17,503 indels within protein coding genes, 13,352
(76.3%) overlap non-coding exons and 4,151 (23.7%)
overlap a protein-coding region. Of these 4,151 protein-
coding indels, 3386 are predicted to cause a frameshift
in the protein sequence, 612 are in-frame indels and the
remainder disrupt splice sites.
Conclusions and discussion
In this paper we describe the first exome sequencing of
pigs. We show that there remain large differences in thed coverage
apped on target % duplicates 1X 10X 30X 40X
59.45 1.13 94.96 81.42 48.26 33.21
73.28 9.48 98.07 94.29 86.99 82.49
67.75 3.78 97.13 91.11 75.02 64.33
imum and mean values for a variety of sequence, mapping and coverage
airs; gigabases sequenced; percentage of reads mapped; percentage of total
ping with the target; estimate of percent PCR duplicates; percent of bases in
target covered at 30X; percent of bases in target covered at 40X.
Figure 5 Heatmap showing percentage of bases at a range of coverage levels for all 96 samples and 16 capture pools.
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published pig genome and those of human and mouse.
The missing coding information can be attributed to
two main factors: (i) regions of the pig genome that are
not yet sequenced, or are poorly assembled; and (ii) gaps
in the protein and RNA evidence available for genome
annotation of the pig.
By adding EST evidence, we were able to increase the
size of the target exome. Not all of the EST evidence will
represent protein-coding genes, we have used the data
simply to define “expressed regions”. The aligned ESTs
do not necessarily make valid gene models (for example,
the order of alignments (HSPs) in the EST may differ
from the order in the genome). Such inconsistencies in
the order of HSPs between EST/cDNA sequences and
the genome sequences, which are probably the result of
errors in short to medium range order and orientation
of contigs in the genome assembly, could account for
some the gaps in the Ensembl gene build. Despite these
concerns, the ESTs provide at least some evidence that
those portions of the genome are transcribed; many of
the regions overlap or are close to existing annotated
genes.
RNA-Seq data will become an increasingly important
resource for genome annotation, in the pig and other ge-
nomes. A combination of exome-capture, RNA-Seq data
and ab initio gene predictions (reviewed in [30]) will be
used to further refine and capture exon boundaries and
gene structures for individual protein-coding loci. In this
paper we focus on the protein-coding exome. The annota-
tion of the non-coding exome within the pig lags signifi-
cantly behind human and mouse and few tools currently
exist to predict the effects of variation in non-coding
expressed DNA. As more data are published in both of
these areas, we anticipate the inclusion of non-coding
RNA genes in the exome capture.
Variants discovered by exome sequencing or whole
genome re-sequencing experiments should be consi-
dered putative until confirmed by an independent assay
or technology. The problems of variant discovery from
current high throughput sequencing technologies are
well documented [31,32]. We have used published best
practice for variant calling and filtering using GATK,
however the number of variants we report in this paper
is likely to be inflated. Variants from exome sequencing
should be subject to further filters, depending on the
nature of the experiment. In particular, insertions and
deletions are problematic, and in a recent study to find
loss-of-function variants in the human genome [33],
the authors applied stringent filters and removed more
than 50% of the candidate variants. Despite these prob-
lems, error rates tend to decline with higher coverage
and can be less than 1%, depending on the software
used [34].The pig exome sequencing produced data of com-
parable quality to published studies in humans, with good
coverage and on-target rates and low PCR-duplication.
The HiSeq 2500 platform is capable of producing 42-45 Gb
of sequence data per lane, therefore it is possible to multi-
plex 6 exome samples per lane. At that level (7.5 Gb of
raw data per sample), exome sequencing will be approxi-
mately one third of the cost of whole genome sequencing
to a depth of 10X. The choice of technology will vary
depending on experimental question – the higher depth
of exome sequencing provides greater power to detect
variants, and cheaper costs allow researchers to process
more samples whereas whole genome sequencing may
uncover variants in non-exome regions, for example regu-
latory regions. With high throughput approaches to the
identification of functional elements such as enhancers
and promoters [35,36], it may be possible to expand the
exome-capture designs to include regulatory regions
whilst retaining the cost advantages.
Exome capture experiments in the domestic pig will
enable the rapid and cheap discovery of mutations rele-
vant to a range of important traits, and facilitate the eradi-
cation of harmful mutations. In addition, as the pig is an
excellent biomedical model for the study of human disease
traits, much of the information on known disease-causing
variants in the human exome can be used to inform
model-based studies involving the pig. This combined
with new methods for genome editing in livestock [37]
will lead to a new and exciting era in livestock and human
disease research. Combined with in-depth knowledge of
gene expression [38], the variants identified by exome
sequencing will prove to be a valuable resource for both
agricultural and medical research.
Methods
Animals
All of the animals involved in this study were raised
under conventional pig breeding and production condi-
tions and were not subjected to any experimental proce-
dures. DNA was prepared from piglet tail clips which is
a conventional husbandry practice to prevent tail biting.
These DNA samples were not collected specifically for
this study, but rather were collected for identification
and genetic diagnosis purposes.
Defining the capture region
The Ensembl [39] gene annotations for the pig from re-
lease 71 were used as a starting point for the design, corre-
sponding to assembly Sscrofa10.2 [12] and the May 2012
genebuild (patched Oct 2012). For comparison, Ensembl
release 71 of both human and mouse was used, with
assembly GRCh37.p10, genebuild April 2011 (patched
Feb 2013) for human and assembly GRCm38.p1, gene-
build Jul 2012 (patched Jan 2013) for mouse.
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loaded from the Ensembl ftp site, and the lengths of non-
overlapping genomic regions corresponding to exons of
protein-coding genes were summed. Having found that
the pig “exome” is smaller than that of human and mouse,
ESTs from build 42 of UniGene [21] Sus scrofa were
mapped to the pig genome. The file Ssc.seq.uniq, repre-
senting the longest, best quality single sequence from each
cluster, was downloaded from the NCBI FTP site, and
used as input for NCBI BLASTN [40]. High-scoring seg-
ment pairs (HSPs) at least 50 bp in length and >90% iden-
tical were chosen; HSPs that mapped more than 200 times
in the genome filtered out; and overlapping HSPs merged.
The resulting regions summed to 22.5 Mb (mega-bases).
These regions were merged with the Ensembl gene anno-
tation using BEDTools [41]. The final set of target gen-
omic regions sums to 58.1 Mb.
Design of probes
The exome capture kits were purchased from Roche
Nimblegen as the SeqCap EZ Developer Library product.
The exome capture region, designated “ensembl + ests”,
was provided to Roche Nimblegen and liquid capture
probes designed according to their standard protocols.
Using probes unique within the genome, that is probes
that map exactly once in the genome, covers only 80%
of the target regions; whereas using probes that map up
to 5 times in the genome covers approximately 98.4% of
the target regions. The latter set of probes was chosen
and used in every downstream analysis. SSAHA was
used to match probes to the genome, using the following
parameters: minPrint = 35 (The minimum number of
matching bases or residues that must be found in the
query and subject sequences before they are considered
as a match and thus printed); maxGap = 5 (Maximum
gap allowed between successive hits for them to count
as part of the same match); maxInsert = 5 (Maximum
number of insertions/deletions allowed between succes-
sive hits for them to count as part of the same match);
wordLength = 12 (Size in base pairs of the words used to
form the hash table); and stepLength = 1 (Number of
base pairs gap between words used to produce hash
table).
Capture, sequencing and bioinformatics
A total of 96 individual pig samples were sequenced.
Initially 96 genomic DNA sequencing libraries were pre-
pared using the Illumina Truseq DNA LT sample prep kit.
Three micrograms of genomic DNA for each sample was
sheared using a Covaris E220 instrument (LGC Genomics
Ltd., Hoddesdon, UK) and purified with AMPure XP
beads (Beckman Coulter Ltd, UK). Fragmentation quality
was verified by running 1 μl of the sample on an Agilent
D1K ScreenTape (Agilent Technologies Ltd. UK.). Theremainder of each sample was used to construct the basic
library. The end repair, A-tail and adapter ligation were
carried out as specified in the Illumina Truseq DNA
sample preparation protocol. The quality of each library
was assessed using Agilent D1K High sensitivity Screen-
Tape to determine the size distribution for each library.
Each Library was subject to precapture PCR following the
Nimbelgen SeqCap EZ library preparation protocol. The
cycling conditions were as follows: initial denaturation at
94°C for 10 minutes; 8 cycles of 94°C for 10 seconds, 60°C
for 70 seconds and 72°C for 45 seconds; final extension at
72°C for 5 minutes, and cooling to 10°C until further use.
The PCR products were purified with AMPure XP bead
and analysed on a ScreenTape D1K (Agilent). The yield of
each library was quantified using the Quant-iT™ Pico-
Green® dsDNA kit (Life Technologies, Paisley, UK).
Samples were pooled randomly in groups of six by mixing
200 ng of DNA for each library to form independent
pools. One microgram of each pool was separately pre-
pared for hybridization with the capture oligomers; the
hybridizations were carried out at 47°C for 70 hours and
the product captured using Streptavidin M-270 Dyna-
beads (Invitrogen, Carlsbad, CA, USA) according to the
NimbleGen SeqCap EZ protocol. The captured DNA
bound to the beads was subjected to LM-PCR as outlined
in the Nimbelgen SeqCap EZ protocol except that the
number of cycles was reduced to 10. The final PCR pro-
duct was cleaned up using Ampure Beads and the quality
of the captured DNA sequencing library assessed.
Each capture pool was analysed using the Agilent D1K
ScreenTape for the size distribution of the captured
DNA. Each pool was quantified by qPCR using the
KAPA Library Quant Kits (KapaBiosystems; Anachem
Ltd, beds, UK). All pools were diluted to a concentration
of 10 nM for storage. The libraries were diluted to a
concentration of 14 pM and loaded onto Illumina V3
paired end flow cell using the cBot (Illumina) according
to the recommended protocol. Within each lane, each
library was assigned unique Illumina adapter indices.
Each pool was then sequenced in a single lane of the
Illumina HiSeq 2500 system, generating 101 bp paired-
end data.
Sus scrofa (assembly version 10.2) was downloaded from
Ensembl (release 70) and used as the reference genome.
The paired-end reads for each of the 96 samples were pre-
processed in order to discard any pair in which at least
one read contains one or more ambiguous bases. All
resulting read pairs were then aligned against the pig
reference genome using BWA [42]. SAMtools [43] was
used to index/sort BAM files and index the reference gen-
ome. PCR and optical duplicates were removed from all
alignments (BAM files) using the Picard MarkDuplicates
tool (http://picard.sourceforge.net). The DepthofCoverage
utility of the Genome Analysis Toolkit [22] was used to
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capture targeted regions in each alignment file.
Variant (SNPs and indels) calling and genotyping across
all 96 samples was performed with GATK following the
general guidelines for whole exome sequencing [27]. Local
re-alignment around indels was performed on alignments
lacking duplicates using the following GATK tools: Realig-
nerTargetCreator, IndelRealigner and FixMateInformation.
Base quality score recalibration (GATK BaseRecalibrator)
was then applied using the known Sus scrofa 10.2 variants
(VCF) from Ensembl release 72 as the known sites. Va-
riant calling was performed using GATK UnifiedGenoty-
per with downsampling to 10X coverage (option -dcov
100) threshold at which at least 90% of the target bases
are covered for most samples (72/96). The results were
filtered using GATK VariantFiltration with the following
parameters: filter out variant calls if located within a clus-
ter where three or more calls are made in a 10 bp window
[clusterWindowSize 10]; filter out variant if there are
at least four alignments with a mapping quality of zero
(MQ0) and if the proportion of alignments mapping
ambiguously corresponds to 1/10th of all alignments
[MQ0 > =4 && ((MQ0/(1.0 * DP)) > 0.1)], DP: total (unfil-
tered) depth over all samples; filter out variants which are
covered by less than 5 reads [DP < 5]; filter out variants
having a low quality score [Q < 50]; filter out variants with
low variant confidence over unfiltered depth of non-refe-
rence samples (QD) [QD < 1.5]; filter out variants based
on strand bias using Fisher's exact test: FS > 60.0 for SNP
calling, FS > 200.0 for indel calling.
The Variant Effect Predictor tool from Ensembl [44]
was used to identify the consequences of all variants in
each sample.
Availability of supporting data
The pig exome design is commercially available through
Roche Nimblegen, design name 130104_Sscr_10_2_MW_
EZ_HX1. The authors will be working on continuous
improvements to this design; therefore scientists inter-
ested in pig exome research are encouraged to contact us.
The SNPs discovered from exome sequencing of the 96
pigs in this study are available in dbSNP, ss numbers
1026566678–1026801732.
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Additional file 1: Table S1. Additional ESTs not found in the genome.
A list of EST accessions and descriptions which do not align to the
current pig reference genome, but which represent important genes we
have added to the capture.
Additional file 2: Table S2. Full statistics for the exome capture results.
Full statistics describing the exome sequencing results, including number
of reads, gigabases per sample, percentage mapped, percentage on
target, percentage duplicates and percentage of bases covered at 1X,
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